VITAL Rhythm Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 25119 participants.
Also called NCT02178410
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 25,119 participants
- Sponsor
- Registry
-
NCT02178410
-
- Other papers using this trial's data
- Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial
- Sex Differences in Atrial Fibrillation Risk: The VITAL Rhythm Study
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02178410. Randomized; triple masking; primary purpose prevention. Start 2012-10 (actual); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VITAL Rhythm Study
- Condition
- Cardiovascular Disease
- Intervention (Dietary supplement)
- Vitamin D3
- Intervention (Drug)
- Omega-3 fatty acids (fish oil)
- Intervention (Dietary supplement)
- Fish oil placebo
- Intervention (Dietary supplement)
- Vitamin D3 placebo
- Lead sponsor
- Brigham and Women's Hospital
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- Cedars-Sinai Medical Center
Record details
- Record id
cardio:ct-nct02178410- Content hash
72be42e2cb41bbb12415ae3e21c724aee67a1c6d8c58d37b1a04dae5fd41c2a0